Posts Tagged: Molecular Engineering
At the Institute of Biomedical Engineering (BME) at the University of Toronto, Professor Leo Chou is developing self-assembling molecular technologies to improve disease diagnostics, therapy, and personalized medicine. His team combines DNA nanotechnology, protein engineering, and computational design to create programmable molecular systems with potential applications in cancer immunotherapy and cellular diagnostics.
Professor Jonathan Rocheleau, a researcher at the University Health Network (UHN) and the Institute of Biomedical Engineering (BME), has received a $100,000 grant from the Canadian Institutes of Health Research (CIHR) to explore a crucial aspect of insulin release—a process essential for maintaining healthy blood sugar levels.
Researchers at the University of Toronto’s Institute of Biomedical Engineering (BME) have found that studying blood flow in leg muscles may help detect cardiovascular disease earlier compared to standardized tests, opening the door to earlier treatment and better outcomes.
Researchers from the Institute of Biomedical Engineering (BME) at the University of Toronto have developed a new method to precisely control the structure and function of immune complexes (ICs) using DNA origami.
Three faculty members at the University of Toronto’s Institute of Biomedical Engineering (BME) have been awarded Canada Research Chairs (CRCs) by the Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Council (NSERC).
Professor Leo Chou has been awarded $130,000 in funding from The Cancer Research Society (CRS) to propel forward an ambitious project aiming to boost the effectiveness of cancer vaccines. This award places him among 100 distinguished Canadian recipients this year, each selected to push boundaries in cancer research with innovative solutions.
U of T Engineering Professor Naomi Matsuura and Thoracic Surgery Professor Kazuhiro Yasufuku speak about their research collaboration that aims to better diagnose and treat lung cancer in the third instalment of the Research Spotlight series.
A recent study led by researchers at the University of Toronto sheds new light on a crucial challenge in the field of nucleic acid drug delivery: how to make lipid nanoparticles (LNPs) break down more quickly in the body. This discovery could pave the way for medicines that can be administered more frequently and with fewer side effects.
Researchers from the Institute of Biomedical Engineering at the University of Toronto have developed a novel MRI contrast agent that may enhance the early detection of inflammatory diseases by targeting nitric oxide (NO), a key molecule involved in the body’s immune response.
Maikawa is one of two U of T Engineering professors to receive funding from the latest round of the Canadian Foundation for Innovation John R. Evans Leaders Fund (CFI-JELF).
Showing 1 - 10 of 61 results